MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchCrypto SummaryFAQAbout
CRDF - Cardiff Oncology Inc
$1.57
0.09(6.08%)9:00:00 PM 12/2/2022
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has completed a Phase I clinical trial in advanced solid tumors; and Phase Ib/II clinical trial for metastatic colorectal cancer in combination with FOLFIRI and Avastin. The company's onvansertib is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. In addition, it develops therapeutics, such as belinostat (Beleodaq); quizartinib (AC220), a development stage FLT3 inhibitor; and bortezomib (Velcade) for the treatment of leukemias, lymphomas, and solid tumor cancers. The company primarily serves pharmaceutical companies. Cardiff Oncology, Inc. has a research collaboration with Nektar Therapeutics for the treatment of colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2020. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
MarketCap68.6M
PE Ratio
PEG Ratio
P/B
P/S (ttm)812.0
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %8%
Held by Institutions %71%
1 Day Vol Adjusted Return0.8
1 Month Vol Adjusted Return0.6
3 Month Vol Adjusted Return-6.2
6 Month Vol Adjusted Return1.0
20 Days SMA Price ZScore1.9
50 Days SMA Price ZScore0.5
12 -26 Days PPO-0.4
1 Month Average Short Volume Ratio34.3
1 Day Volume Change ZScore0.0
1 Month Daily Vol4.7
Related Topics
leak data

Related Topics

Peers

Related Peers

Stock news